Alloprevotella

Taxonomy and Distinction from Prevotella#

Phylum: Bacteroidetes. Family: Prevotellaceae. Genus: Alloprevotella (formerly grouped with Prevotella; reclassified ~2015 based on 16S and genomic analysis).

Key species: A. rava, A. melaninogenica, A. tannerae, A. enocis. Critical distinction: While related to Prevotella, Alloprevotella possesses distinct glycan-degradation gene clusters and SCFA production profiles that confer different metabolic and immune effects.

Protective Association#

Significantly depleted in T2D patients across multiple independent cohorts (Chinese, European, North American populations) (;^{[1]Li 2020 — Implication of the Gut Microbiome Composition of Type 2 Diabetic Patients from Northern ChinaQian Li, Yujun Chang, Ke Zhang et al. · 2020Open reference 1 ↓[2]Dash 2023 — Functional Alterations and Predictive Capacity of Gut Microbiome in Type 2 DiabetesNihar Ranjan Dash, Mohammad T. Al Bataineh, Rohia Alili et al. · 2023Open reference 2 ↓}).

Depletion magnitude correlates with HbA1c levels and insulin resistance severity (^{[3]Salamone 2021 — The Relationship between Gut Microbiota, Short-Chain Fatty Acids and Type 2 Diabetes: The Role of Dietary FibreDominic Salamone, Angela Albarosa Rivellese, Claudia Vetrani · 2021Open reference 3 ↓}). Restoration of Alloprevotella abundance associated with improved insulin sensitivity in dietary intervention trials (^{[4]Herrema 2020 — Intestinal Microbial Metabolites in Human Metabolism and Type 2 DiabetesHilde Herrema, Jan Hendrik Niess · 2020Open reference 4 ↓}).

Present in healthy controls at 1–5% relative abundance; typically <0.1% in T2D (^{[1]Li 2020 — Implication of the Gut Microbiome Composition of Type 2 Diabetic Patients from Northern ChinaQian Li, Yujun Chang, Ke Zhang et al. · 2020Open reference 1 ↓}).

Mechanistic Protection Against Insulin Resistance#

Propionate Production and GPR43 Signaling. Alloprevotella's primary SCFA output is propionate (via propionyl-CoA synthetase and associated enzymes) (^{[3]Salamone 2021 — The Relationship between Gut Microbiota, Short-Chain Fatty Acids and Type 2 Diabetes: The Role of Dietary FibreDominic Salamone, Angela Albarosa Rivellese, Claudia Vetrani · 2021Open reference 3 ↓}).

Propionate activates GPR43 (free fatty acid receptor 2) on intestinal epithelial cells and immune cells (Maslowski et al. 2009 Nature;^{[5]Hoyles 2018 — Microbiome-Host Systems Interactions: Protective Effects of Propionate upon the Blood-Brain BarrierLesley Hoyles, Tom Snelling, Umm-Kulthum Umlai et al. · 2018Open reference 5 ↓}).

GPR43 signaling strengthens intestinal barrier integrity and reduces systemic LPS translocation (^{[4]Herrema 2020 — Intestinal Microbial Metabolites in Human Metabolism and Type 2 DiabetesHilde Herrema, Jan Hendrik Niess · 2020Open reference 4 ↓}). Propionate also activates PPAR-γ in colonocytes, promoting insulin sensitivity (Den Besten et al. 2013 J Lipid Res).

Glucose and Lipid Metabolism. Alloprevotella fermentation produces succinate and lactate alongside propionate. These metabolites improve hepatic glucose homeostasis and reduce hepatic steatosis (NAFLD).

Propionate directly suppresses de novo lipogenesis in the liver.

Intestinal Barrier Function and Endotoxemia. Alloprevotella's propionate production maintains tight junction protein expression (claudin-2, occludin, ZO-1) (^{[5]Hoyles 2018 — Microbiome-Host Systems Interactions: Protective Effects of Propionate upon the Blood-Brain BarrierLesley Hoyles, Tom Snelling, Umm-Kulthum Umlai et al. · 2018Open reference 5 ↓}). Depletion is associated with increased gut permeability and elevated fasting endotoxemia (LPS) (Cani et al.

2007 Diabetes).

LPS is a key driver of systemic Metal-Driven Inflammation and insulin resistance in T2D (^{[4]Herrema 2020 — Intestinal Microbial Metabolites in Human Metabolism and Type 2 DiabetesHilde Herrema, Jan Hendrik Niess · 2020Open reference 4 ↓}).

Bile Acid Metabolism. Alloprevotella possesses moderate bile salt hydrolase (BSH) activity. Secondary bile acids produced support FXR and TGR5 signaling, enhancing insulin sensitivity.

Depletion reduces secondary bile acid diversity, impairing metabolic signaling.

Immune Tolerance and Th17 Suppression. Propionate produced by Alloprevotella activates HDAC inhibition in dendritic cells. This skews immune differentiation toward Tregs and away from pro-inflammatory Th17 cells.

Loss of Alloprevotella correlates with elevated Th17 abundance and increased intestinal IL-17 production, which impairs barrier function.

Oral Health and Periodontal Microbiota#

Alloprevotella is a major member of healthy gingival microbiota (Downes et al. 2013 IJSEM—original Alloprevotella description). Competes for niches with pathogenic Prevotella species and periodontal pathogens.

Associated with stable, non-inflamed periodontal tissues.

Depleted in periodontitis and aggressive gingivitis (Abusleme et al. 2013 ISME J).

Type 1 Diabetes and the Oral-Gut Axis#

Alloprevotella depletion has also been observed in T1D cohorts alongside SCFA depletion (^{[6]Bile Acids and T1D — Calprotectin and SCFA AssociationsVarious · 2023Open reference 6 ↓}). The oral-gut axis is relevant: as Alloprevotella is a shared oral–intestinal commensal, systemic depletion may reflect broader loss of mucosal SCFA-producing diversity.

Detection and Quantification#

16S rRNA profiling: Genus-level quantification; species-level resolution requires additional markers. Functional markers: propionyl-CoA synthetase gene copies; malonyl-CoA decarboxylase copies. Metabolomics: Fecal and serum propionate levels as proxy for Alloprevotella activity.

Typical abundance: 1–5% of fecal microbiota in healthy controls; <0.5% in T2D.

Restoration and Dietary Associations#

High-fiber diets: Selectively enrich Alloprevotella (resistant starch > 15g/day shows strongest associations). Polyphenol-rich foods: Berries, pomegranate, tea; secondary metabolites favor Alloprevotella growth. Whole grains and legumes: Beta-glucans and arabinoxylan substrates support abundance.

Mediterranean dietary pattern: Strong association with Alloprevotella restoration in T2D intervention trials.